UMIN-CTR History

Name：　　UMIN ID：

Unique ID issued by UMIN	UMIN000015838
Receipt number	R000018430
Scientific Title	Phase 2 clinical study of evaluation of efficacy of switch to eribulin chemotherapy in patients with locally advanced breast cancer or metastatic breast cancer who are not responsive to combination regimen of Docetaxel, Doxorubicin and Cyclophosphamide (TAC) and continuation of TAC chemotherapy in responding patients to TAC
Date of disclosure of the study information	2014/12/03
Last modified on	2014/12/03 21:55:23

---